Polyrizon Documenti
Documenti
0
Ticker
PLRZ
ISIN
IL0011814113
Polyrizon SEC Filings
Tipo | Rapporto | Data |
|---|---|---|
| Nessun documento disponibile | ||
Polyrizon Documenti 2026
Questa pagina contiene tutti i documenti ufficiali e i filing SEC dell'azione Polyrizon (PLRZ, ISIN: IL0011814113). Sono incluse le relazioni annuali (Form 10-K), le relazioni trimestrali (Form 10-Q) e le transazioni degli insider (Form 4). Attualmente sono disponibili 0 documenti. I dati vengono aggiornati regolarmente per offrire agli investitori una panoramica completa dei depositi regolamentari di Polyrizon.
Polyrizon Analisi delle Azioni
Polyrizon Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements.